1. Home
  2. VALU vs BNTC Comparison

VALU vs BNTC Comparison

Compare VALU & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Value Line Inc.

VALU

Value Line Inc.

HOLD

Current Price

$40.51

Market Cap

341.6M

Sector

Finance

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$8.81

Market Cap

313.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VALU
BNTC
Founded
1931
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
341.6M
313.9M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
VALU
BNTC
Price
$40.51
$8.81
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $24.33
AVG Volume (30 Days)
1.4K
★ 167.3K
Earning Date
09-14-2026
11-13-2026
Dividend Yield
★ 3.15%
N/A
EPS Growth
4.55
★ 6.67
EPS
★ 0.50
N/A
Revenue
★ $36,257,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$89.58
★ N/A
Revenue Growth
★ 1.08
N/A
52 Week Low
$32.00
$8.52
52 Week High
$44.79
$16.76

Technical Indicators

Market Signals
Indicator
VALU
BNTC
Relative Strength Index (RSI) 67.77 25.94
Support Level $36.31 N/A
Resistance Level N/A $13.49
Average True Range (ATR) 1.25 0.79
MACD 0.44 -0.11
Stochastic Oscillator 83.64 7.42

Price Performance

Historical Comparison
VALU
BNTC

About VALU Value Line Inc.

Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and makes available copyright data, including a ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets its products under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing, and The Most Trusted Name in Investment Research. Its only operating segment is Publishing.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Share on Social Networks: